The poor clinical results that are frequently reported for arteriovenous fistulae (AVF) for hemodialysis are typically due to failure of AVF maturation. We hypothesized that early AVF maturation is associated with generation of reactive oxygen species and activation of the hypoxia-inducible factor-1 (HIF-1) pathway, potentially promoting neointimal hyperplasia. We tested this hypothesis using a previously reported mouse AVF model that recapitulates human AVF maturation. Methods: Aortocaval fistulae were created in C57Bl/6 mice and compared with sham-operated mice. AVFs or inferior vena cavas were analyzed using a microarray, Amplex Red for extracellular H 2 O 2 , quantitative polymerase chain reaction, immunohistochemistry, and immunoblotting for HIF-1a and immunofluorescence for NOX-2, nitrotyrosine, heme oxygenase-1 (HO-1), and vascular endothelial growth factor (VEGF)-A. Results: Oxidative stress was higher in AVF than that in control veins, with more H 2 O 2 (P ¼ 0.007) and enhanced nitrotyrosine immunostaining (P ¼ 0.005). Immunohistochemistry and immunoblot showed increased HIF-1a immunoreactivity in the AVF endothelium; HIF-1 targets NOX-2, HO-1 and VEGF-A were overexpressed in the AVF (P < 0.01). AVF expressed increased numbers of HIF-1a (P < 0.0001) and HO-1 (P < 0.0001) messenger RNA transcripts. Conclusions: Oxidative stress increases in mouse AVF during early maturation, with increased expression of HIF-1a and its target genes NOX-2, HO-1, and VEGF-A. These results suggest that clinical strategies to improve AVF maturation could target the HIF-1 pathway.
BACKGROUND
Although arteriovenous fistulae (AVF) are the preferred vascular access for hemodialysis for patients with end-stage renal disease, the functional results are not optimal, with 1-year patency frequently reported in the range of 60e65%. 1e3 AVF maturation is complex and requires cellular migration and proliferation, as well as extracellular matrix deposition and remodeling to achieve outward remodeling and wall thickening. 4, 5 Both outward remodeling, for example increased diameter, and wall thickening are needed for the vein to adapt to the arterial environment, where hemodynamic conditions are different and oxygen tension is increased. The forces that control venous adaptation to the arterial environment are not well understood, as insufficient diameter expansion can lead to failure of AVF maturation, whereas excessive wall thickening can lead to the development of juxta-anastomotic stenosis, both of which prevent clinical use of the fistula.
Molecular mechanisms of venous remodeling remain poorly understood but include endothelial signaling via endothelial nitric oxide synthase and endothelin-1 signaling, 6e9 inflammatory and coagulation pathways via interleukine-6, interleukine-8, tumor necrosis factor alpha, and interleukine-10, 7, 8 extracellular matrix regulators including matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9), tissue inhibitor of metalloproteinase, and a disintegrin and metalloproteinase with thrombospondin motifs-1, 10e12 and growth factors and cell adhesion molecules such as insulin-like growth factor-1, platelet derived growth factor, vascular endothelial growth factor (VEGF), selectin, and vascular cell adhesion molecule-1. 7,13e15 Although much research focuses on the mediators that control the response to arterial hemodynamic forces, another mechanism important during AVF maturation may involve the response of the vein to the altered oxygenation of the arterial environment. Hypoxia-inducible factor-1 (HIF-1) is a key transcription factor that regulates the cellular response to oxygen and hypoxic injury. 16 HIF-1 can also be stabilized in normoxic conditions as a consequence of cell injury and oxidative stress. 17 Oxidative stress has been shown to be present in the vein-graft anastomosis 18 and therefore can play a similar role in increasing HIF-1 expression during AVF maturation. Downstream mechanisms of the HIF-1 pathway include activation of the VEGF pathway, which promotes angiogenesis and arteriogenesis and regulates vascular tone, via heme oxygenase-1 (HO-1), all of which can stimulate neointimal hyperplasia. 13 Therefore, HIF-1 is an attractive therapeutic target for vascular therapy using pharmacologic agents or gene therapy. 19, 20 The aim of the present study was to determine if expression of HIF-1 and its downstream targets increases during early AVF maturation, using a mouse model of AVF maturation that recapitulates human AVF maturation. 21 We hypothesized that HIF-1 expression increases during AVF maturation; and therefore, this pathway might be a candidate for translational therapy to improve AVF maturation.
METHODS

Experimental Animals
All animal experiments were performed in compliance with federal guidelines and with approval from the Institutional Animal Care and Use Committee of Yale University. The appropriate anesthesia and analgesia were given as described in our previous studies. 21, 22 Male C57/BL6 mice (body weight: 20e30 g) were used for this study. Briefly, 4% isoflurane in 0.8 L/min O 2 was delivered via an isoflurane vaporizer for induction and decreased to 2e3% after mice were anesthetized. Under general anesthesia, a midline laparotomy was made, and the aorta and inferior vena cava (IVC) were exposed. The proximal infrarenal aorta and distal aorta were dissected for clamp placement and needle puncture, respectively; the vena cava was not dissected free from the aorta. After the aorta was clamped just below the left renal artery, a 25-gauge needle was used to puncture the aorta through into the IVC. The surrounding connective tissue was used for hemostatic compression. No heparin was used during the procedure. Successful creation of the AVF was characterized by hemostasis and visible pulsatile arterial blood flow in the IVC. Doppler ultrasound was performed both preoperatively and postoperatively to confirm the presence of the AVF, using the Vevo770 High Resolution Imaging System (VisualSonics) with probe RMV704 (20e60 MHz) under general anesthesia as described previously.
Gene Expression Microarray Analysis
Gene expression in the venous limb of the AVF was compared with that in the IVC of sham mice (day 7; n ¼ 4), as described elsewhere. 23 Briefly, RNA was isolated from pooled samples and analyzed for whole genome gene expression using the Mouse Gene 1.0 ST array (Cat. No. 901168; Affymetrix, Santa Clara, CA). Significant changes between AVF and sham veins in gene expression were determined using a false discovery rate less than 0.05 and a fold change of more than 2.0 or less than À2.0. Further experiments were performed regarding HIF-1a and its downstream genes involving angiogenesis and vascular tone regulation.
Measurement of H 2 O 2 Production by Spectrophotometry
The Amplex Red assay kit (Life Technologies) was used for quantitative, specific, extracellular detection of H 2 O 2 24 according to the manufacturer's protocol. 25e27 Briefly, before euthanasia, mice were infused with a modified Krebs-Ringer solution containing 145-mM NaCl, 5.7-mM sodium phosphate, 4.86-mM KCl, 0.54-mM CaCl2, 1.22-mM MgSO 4 , 5.5-mM glucose, at pH 7.4 and 4 C. The venous limb of AVF mice or controls was then excised, and adherent fat or thrombi were removed. Vessels were cut in 2-mm rings and transferred to a 96-well plates where they were incubated with Amplex Red (10-acetyl-3,7-dihydroxyphenoxazine) (50 mM) and horseradish peroxidase (0.1 U/mL), for 1 hr at 37 C and protected from light. H 2 O 2 standards (0e0.125 mM) were used as control. A spectrophotometer was used to measure absorbance at 560 nm. Background absorbance, measured in a control reaction without H 2 O 2 or sample, was subtracted, and H 2 O 2 accumulation was normalized for dry tissue weight (picomoles per milligram of dry tissue).
RNA Extraction and Quantitative PCR Analysis
The venous limb of the AVF or the control IVC were harvested under general anesthesia just before euthanasia. Expression for the gene of interest was determined using quantitative real-time PCR. Total RNA from the vessels was isolated using the RNeasy Mini kit with digested DNase I (Qiagen). RNA quality was confirmed by the 260-to-280-nm ratio. The SuperScript III First-Strand Synthesis Supermix (Invitrogen) was used for reverse transcription. SYBR Green Supermix (Bio-Rad Laboratories) was used for real-time quantitative PCR, with a 35-cycle amplification using the iQ5 RealTime PCR Detection System (Bio-Rad Laboratories). Primer efficiencies were determined by melt curve analysis. All samples were normalized by amplification of a housekeeping gene RNA. Primers sequences are listed in Table I .
SDS-PAGE and Western Blot Analysis
Explanted venous limbs of AVFs and controls were snap frozen in liquid nitrogen and stored at À80 until further process. Protein samples were obtained by mechanical grinding of each vessel in ice-cold lysis buffer (50-mM Tris-HCl, 1% tergitol-type NP-40, 0.1% sodium dodecylsulfate, 0.1% deoxycholic acid, 0.1-mM ethylenediaminetetraacetic acid, 0.1-
, protease, and phosphatase inhibitors). Protein concentration was determined by spectrophotometry (DC Protein assay, Bio-Rad Laboratories). Equal amounts of protein for each group were then loaded for SDS-page, transferred on polyvinylidene difluoride membranes, and followed by Western blot analysis. The membranes were incubated overnight at 4 C with one of the following primary antibody: anti-b-Actin (Sigma Aldrich) 1:5000 and anti-HIF-1a (Novus Biologicals) 1:2000. Secondary antibodies were HRPlinked. Signals were detected using the ECL detection reagent (Life Technologies).
Immunohistochemistry
At euthanasia, en bloc extraction of the AVF or the infrarenal aorta + IVC (control) was performed after perfusion fixation with phosphate buffered saline (PBS) followed by 10% formalin. The tissue block was then embedded in paraffin and cut into 5-mm cross-sections. Immunohistochemistry was performed using the Dako EnVision + Dual Link System-HRP (Dako, Carpinteria, CA). Sections were heated in citric acid buffer (pH 6.0) at 100 C for 10 min using the Lab Vision PT Module (Thermo Scientific, Kalamazoo, MI) for antigen retrieval, then treated with 0.3% hydrogen peroxide in methanol for 30 min at room temperature to block endogenous peroxidase activity. They were incubated with 5% normal goat serum in PBS (pH 7.4) containing 0.05% Triton X-100 for 1 hr at room temperature to block nonspecific protein-binding sites. Sections were then incubated at 4 C with the anti-HIF-1a primary antibody diluted at 1:50 in PBS containing 0.05% Triton X-100. After an overnight incubation, sections were incubated with EnVision reagents for 1 hr at room temperature and treated with the Dako Liquid DAB + Substrate Chromogen System (Dako) to visualize the reaction products. Finally, sections were counterstained with Dako Mayer's 
Immunofluorescence
Tissue extraction procedure was the same as previously mentioned. Sections were deparaffined and blocked with 5% bovine serum albumin before incubation with antibodies directed against HO-1 (ab13243, Abcam, Cambridge, MA), Nitrotyrosin (ab7048), NOX-2 (ab31092), VEGFA (ab51745), and vWF (ab11713) overnight at 4 C. Secondary antibodies were linked to Alexa Fluor 488 and 568 (Invitrogen, Carlsbad, CA). Sections were stained with 4',6-diamidino-2-phelylindole (DAPI, Invitrogen) to mark nuclei. Nitrotyrosine staining density was reported as density per area. Positively staining cells for NOX-2 and HO-1 were counted in 5 highpower fields.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism (version 6) software. All data are means ± SD. Unpaired Student's t-test was performed after spectrophotometry, densitometry, and cell count analysis. One-way analysis of variance and post hoc analysis were performed for the quantitative polymerase chain reaction (qPCR) experiment. Densitometry analysis after Western blot was performed on scanned images using Quantity One software (Bio-Rad). After adjustment to multiple comparisons, P values less than 0.05 were considered significant.
RESULTS
We previously reported that the mouse aortocaval AVF model recapitulates human AVF maturation. 21 Using this model, we also previously reported a microarray analysis (day 7) with direct qPCR validation showing distinct temporal patterns of expression of several extracellular matrix components, suggesting a highly regulated response to injury during early AVF maturation. 23 Interestingly, the microarray analysis showed downregulation of 27 of the 83 genes involved in the oxidative phosphorylation pathway, downregulation of 12 of the 18 genes involved in mitochondrial long-chain fatty acid beta-oxidation, and 10 of the 13 genes involved in mitochondrial unsaturated fatty acid betaoxidation (Table II) , suggesting the presence of oxidative stress during early AVF maturation.
To determine if oxidative stress is present during early AVF maturation, explanted AVF and control veins (day 3) were incubated in Amplex Red reagent to directly measure H 2 O 2 excretion; spectrophotometry showed that extracellular H 2 O 2 was significantly higher in AVF than that in control veins (Fig. 1) . To confirm increased oxidative stress during AVF maturation, immunofluorescence staining of the AVF showed increased nitrotyrosine at both days 3 and 7 compared with control veins (Fig. 2A, B) . Interestingly, nitrotyrosine was increased in both the endothelium and the media of the AVF, suggesting colocalization of oxidative stress with the site of future development of neointimal hyperplasia ( Fig. 2A) . These results suggest that the oxidative stress pathway is active during early AVF maturation.
Since oxidative stress is present during AVF maturation, we determined if HIF-1a and its targets NOX-2, HO-1, and VEGF-A are expressed during early AVF maturation. Immunofluorescence staining of the AVF showed increased immunoreactivity of NOX-2, HO-1, and VEGF-A at both days 3 and 7 compared with control veins (Fig. 2A, CeE) . Similar to the distribution of nitrotyrosine, NOX-2, HO-1, and VEGF-A immunoreactivity was present throughout the AVF (Fig. 2A) . Similarly, HIF-1a protein expression was increased in AVF compared with control veins, using both Western blot ad immunohistochemistry that showed the endothelial location of HIF-1a in the AVF (Fig. 3) .
Since protein expression of HIF-1a, as well as its targets NOX-2, HO-1, and VEGF-A, is increased during early AVF maturation, we examined the RNA expression of these components of the oxidative stress pathway. Microarray analysis (day 7) suggested sustained increased RNA expression of HIF-1a, NOX-2, and HO-1 but not VEGF-A (Table III) . qPCR confirmed elevated expression of HIF-1a and HO-1 but not VEGF-A (Fig. 4) ; NOX-2 expression could not be determined (data not shown). These results suggest complex patterns of expression regulating the oxidative stress pathway during AVF maturation (Fig. 5) , for example, oxidative stress is present and HIF-1a expression is increased during AVF maturation.
DISCUSSION
In a mouse AVF model that recapitulates human AVF maturation, oxidative stress is present during early venous adaptation to the arterial environment (days 3 and 7; Figs. 1 and 2) . Expression of both HIF-1a, as well as its downstream targets NOX-2 and HO-1, was increased in the AVF compared with control veins (Figs. 3 and 4) . These results colocalize the presence of HIF-1 with oxidative stress during early AVF maturation, suggesting a potential target to enhance early venous adaptation to the arterial environment.
Oxidative stress is associated with end-stage renal disease and stimulates synthesis and secretion of reactive oxygen species (ROS).
28e30 Several studies have shown increased oxidative stress and superoxide anions in the neointimal hyperplasia lesions of AVF. 18, 31 ROS is known to regulate diverse processes during venous adaptation, including smooth muscle cell migration and proliferation and activation of latent MMP, 32e34 similar to the function of MMP during development of venous pathology. 35 ROS and particularly hydrogen peroxide also play a significant role in the hypoxia pathway by activating HIF-1a, via the activation of the NADPH oxydase. 36 We showed increased excreted hydrogen peroxide, nitrotyrosine staining, and NOX-2 staining in the venous limb of the AVF during early maturation ( Figs. 1 and 2) , confirming the presence of oxidative stress during AVF maturation.
HIF-1 is a transcription factor that consists of 2 subunits. During normoxic conditions, the HIF-1a subunit is degraded in the cytosol, whereas the HIF-1b subunit is constitutively present in the nucleus. However, during hypoxic conditions, there is inhibited degradation of the HIF-1a subunit, which then enters the nucleus to binds to the HIF1b and other cofactors, activating the hypoxia response element of some gene promoters to stimulate this pathway functions. 16 We show that increased expression of HIF-1a also occurs early during AVF maturation, which is localized to the venous endothelium (Fig. 3B) . These data suggest that AVF creation may induce either hypoxic or oxidative injury in the fistula endothelium, consistent with other models of intimal hyperplasia following endothelial injury. 36, 37 Hypoxia is suspected of playing a role in the pathogenesis of various diseases of the vascular wall. HIF pathway activation has been studied in the pathophysiology of both atherosclerosis (including foam cell formation, cellular proliferation, plaque ulceration, hemorrhage, and rupture) and arterial aneurysms (including weakening, dilation, and rupture of the arterial wall). 19 Misra et al. showed increased HIF-1a expression and other hypoxia-related proteins in a mouse model of failing AVF with renal insufficiency. 12 Our data show HIF-1a expression during normal AVF maturation, suggesting that this transcription factor is not necessarily deleterious. However, it is unclear whether this increase is mechanistic or a secondary phenomenon during AVF maturation and/or failure and whether its role evolves in time. Therefore, it is not clear whether this pathway should be upregulated or 19 Similarly, it is not surprising that changes in messenger RNA expression of numerous proteins involved in metabolism and mitochondrial ROS production occur during AVF maturation (Table II) ; however, these data are consistent with downregulation of the oxidative phosphorylation pathways of metabolism, suggesting that energy production during AVF maturation may be via alternative anaerobic metabolic pathways, such as the glycolytic, pentose phosphate, or glutamine pathways.
CONCLUSIONS
In a mouse model of AVF maturation, AVF creation was rapidly followed by increased release of ROS and increased HIF-1a protein expression. NOX-2, HO-1, and VEGF-A, target proteins induced by HIF-1, were also highly expressed. These data suggest that AVF creation induces hypoxic injury in the wall of the fistula, and triggers the HIF-1 pathway. Therefore, early manipulation of the HIF-1 pathway is a potential therapeutic target to enhance AVF maturation. normalized to day 0 expression; P < 0.0001; n ¼ 5e8. *, P ¼ 0.0063 (day 1); *, P ¼ 0.0033 (day 3); *, P < 0.0001 (day 7). (C) Bar graph shows RNA expression of VEGF-A during AVF maturation relative to sham veins, normalized to day 0 expression; P ¼ 0.0001; n ¼ 5e8. 
